Wellington Management Group
FLXN

Wellington Management Group’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Wellington Management Group’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-650
Closed -$286K – 2369
2017
Q4 		$286K Buy
+650
New +$15.9K ﹤0.01% 2133

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Wellington Management Group's FLXN Position: Q1 2020 in Review

Wellington Management Group sold out of Flexion Therapeutics, Inc. (FLXN) in Q1 2020, closing a stake of 55,458 shares — an estimated $1.15M sold.

Wellington Management Group first reported a position in FLXN in Q2 2015 and held it in 19 quarters. The position peaked at $24.9M in Q4 2015. 123 funds tracked by Wall St. Rank hold FLXN as of Q1 2020.

  • Wellington Management Group reported no remaining Flexion Therapeutics, Inc. position as of Q1 2020 after selling out during the quarter.
  • Wellington Management Group sold 55,458 Flexion Therapeutics, Inc. shares in Q1 2020, an estimated $1.15M.
  • Wellington Management Group first reported a position in Flexion Therapeutics, Inc. in Q2 2015 and held it in 19 quarters.
  • Wellington Management Group's Flexion Therapeutics, Inc. position peaked at $24.9M in Q4 2015.
  • 123 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q1 2020.

Based on Wellington Management Group's 13F filing for Q1 2020, filed 14 May 2020.